0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global NGS-based RNA-sequencing Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-25L842
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global NGS based RNA sequencing Market Insights and Forecast to 2028
BUY CHAPTERS

Global NGS-based RNA-sequencing Market Insights, Forecast to 2030

Code: QYRE-Auto-25L842
Report
December 2024
Pages:117
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

NGS-based RNA-sequencing Market Size

The global NGS-based RNA-sequencing market is projected to grow from US$ 3000 million in 2024 to US$ 7862.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 17.4% during the forecast period.

NGS-based RNA-sequencing Market

NGS-based RNA-sequencing Market

Gene expression studies can also involve looking at profiles or patterns of expression of several genes. RNA sequencing (RNA-Seq) leverages the advantages of next-generation sequencing (NGS) to detect and quantify RNA in a biological sample at a given point in time.
Market Analysis and Insights: Global NGS-based RNA-sequencing Market
A significant driver in the NGS-based RNA-sequencing market is the increasing demand for comprehensive and high-throughput analysis of RNA molecules for research and clinical applications. Next-generation sequencing (NGS) technology enables researchers to examine gene expression, identify alternative splicing events, and detect RNA modifications at an unprecedented scale. However, a notable challenge in this market is the need for data analysis and storage solutions. Managing the vast amount of data generated by NGS-based RNA-sequencing while ensuring data accuracy, security, and accessibility poses a significant challenge. Bioinformatics tools, cloud-based solutions, and data management strategies must be continually developed to streamline data analysis and storage processes, facilitating the broader adoption of NGS-based RNA-sequencing in genomics research and precision medicine.
Report Covers:
This report presents an overview of global market for NGS-based RNA-sequencing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of NGS-based RNA-sequencing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for NGS-based RNA-sequencing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the NGS-based RNA-sequencing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global NGS-based RNA-sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for NGS-based RNA-sequencing revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of NGS-based RNA-sequencing Market Report

Report Metric Details
Report Name NGS-based RNA-sequencing Market
Accounted market size in 2024 US$ 3000 in million
Forecasted market size in 2030 US$ 7862.7 million
CAGR 17.4
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
Segment by Application
  • Research & Academia
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Illumina, Thermo Fischer Scientific, Oxford Nanopore, Agilent Technologies, BGI, PerkinElmer, QIAGEN, Eurofins Scientific, Roche, Takara Bio, GENEWIZ, Hamilton, Macrogen, Zymo Research, Tecan Genomics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of NGS-based RNA-sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of NGS-based RNA-sequencing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, NGS-based RNA-sequencing revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is NGS-based RNA-sequencing Market growing?

Ans: The NGS-based RNA-sequencing Market witnessing a CAGR of 17.4 during the forecast period 2025-2030.

What is the NGS-based RNA-sequencing Market size in 2030?

Ans: The NGS-based RNA-sequencing Market size in 2030 will be US$ 7862.7 million.

Who are the main players in the NGS-based RNA-sequencing Market report?

Ans: The main players in the NGS-based RNA-sequencing Market are Illumina, Thermo Fischer Scientific, Oxford Nanopore, Agilent Technologies, BGI, PerkinElmer, QIAGEN, Eurofins Scientific, Roche, Takara Bio, GENEWIZ, Hamilton, Macrogen, Zymo Research, Tecan Genomics

What are the Application segmentation covered in the NGS-based RNA-sequencing Market report?

Ans: The Applications covered in the NGS-based RNA-sequencing Market report are Research & Academia, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, Others

What are the Type segmentation covered in the NGS-based RNA-sequencing Market report?

Ans: The Types covered in the NGS-based RNA-sequencing Market report are Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-molecule Real-time Sequencing, Nanopore Sequencing

Recommended Reports

RNA Sequencing Markets

Next Generation Sequencing

Sequencing Kits & Prep

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global NGS-based RNA-sequencing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Sequencing by Synthesis
1.2.3 Ion Semiconductor Sequencing
1.2.4 Single-molecule Real-time Sequencing
1.2.5 Nanopore Sequencing
1.3 Market by Application
1.3.1 Global NGS-based RNA-sequencing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Research & Academia
1.3.3 Hospitals & Clinics
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global NGS-based RNA-sequencing Market Perspective (2019-2030)
2.2 Global NGS-based RNA-sequencing Growth Trends by Region
2.2.1 NGS-based RNA-sequencing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 NGS-based RNA-sequencing Historic Market Size by Region (2019-2024)
2.2.3 NGS-based RNA-sequencing Forecasted Market Size by Region (2025-2030)
2.3 NGS-based RNA-sequencing Market Dynamics
2.3.1 NGS-based RNA-sequencing Industry Trends
2.3.2 NGS-based RNA-sequencing Market Drivers
2.3.3 NGS-based RNA-sequencing Market Challenges
2.3.4 NGS-based RNA-sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue NGS-based RNA-sequencing by Players
3.1.1 Global NGS-based RNA-sequencing Revenue by Players (2019-2024)
3.1.2 Global NGS-based RNA-sequencing Revenue Market Share by Players (2019-2024)
3.2 Global NGS-based RNA-sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of NGS-based RNA-sequencing, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global NGS-based RNA-sequencing Market Concentration Ratio
3.4.1 Global NGS-based RNA-sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by NGS-based RNA-sequencing Revenue in 2023
3.5 Global Key Players of NGS-based RNA-sequencing Head office and Area Served
3.6 Global Key Players of NGS-based RNA-sequencing, Product and Application
3.7 Global Key Players of NGS-based RNA-sequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 NGS-based RNA-sequencing Breakdown Data by Type
4.1 Global NGS-based RNA-sequencing Historic Market Size by Type (2019-2024)
4.2 Global NGS-based RNA-sequencing Forecasted Market Size by Type (2025-2030)
5 NGS-based RNA-sequencing Breakdown Data by Application
5.1 Global NGS-based RNA-sequencing Historic Market Size by Application (2019-2024)
5.2 Global NGS-based RNA-sequencing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America NGS-based RNA-sequencing Market Size (2019-2030)
6.2 North America NGS-based RNA-sequencing Market Size by Type
6.2.1 North America NGS-based RNA-sequencing Market Size by Type (2019-2024)
6.2.2 North America NGS-based RNA-sequencing Market Size by Type (2025-2030)
6.2.3 North America NGS-based RNA-sequencing Market Share by Type (2019-2030)
6.3 North America NGS-based RNA-sequencing Market Size by Application
6.3.1 North America NGS-based RNA-sequencing Market Size by Application (2019-2024)
6.3.2 North America NGS-based RNA-sequencing Market Size by Application (2025-2030)
6.3.3 North America NGS-based RNA-sequencing Market Share by Application (2019-2030)
6.4 North America NGS-based RNA-sequencing Market Size by Country
6.4.1 North America NGS-based RNA-sequencing Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America NGS-based RNA-sequencing Market Size by Country (2019-2024)
6.4.3 North America NGS-based RNA-sequencing Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe NGS-based RNA-sequencing Market Size (2019-2030)
7.2 Europe NGS-based RNA-sequencing Market Size by Type
7.2.1 Europe NGS-based RNA-sequencing Market Size by Type (2019-2024)
7.2.2 Europe NGS-based RNA-sequencing Market Size by Type (2025-2030)
7.2.3 Europe NGS-based RNA-sequencing Market Share by Type (2019-2030)
7.3 Europe NGS-based RNA-sequencing Market Size by Application
7.3.1 Europe NGS-based RNA-sequencing Market Size by Application (2019-2024)
7.3.2 Europe NGS-based RNA-sequencing Market Size by Application (2025-2030)
7.3.3 Europe NGS-based RNA-sequencing Market Share by Application (2019-2030)
7.4 Europe NGS-based RNA-sequencing Market Size by Country
7.4.1 Europe NGS-based RNA-sequencing Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe NGS-based RNA-sequencing Market Size by Country (2019-2024)
7.4.3 Europe NGS-based RNA-sequencing Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China NGS-based RNA-sequencing Market Size (2019-2030)
8.2 China NGS-based RNA-sequencing Market Size by Type
8.2.1 China NGS-based RNA-sequencing Market Size by Type (2019-2024)
8.2.2 China NGS-based RNA-sequencing Market Size by Type (2025-2030)
8.2.3 China NGS-based RNA-sequencing Market Share by Type (2019-2030)
8.3 China NGS-based RNA-sequencing Market Size by Application
8.3.1 China NGS-based RNA-sequencing Market Size by Application (2019-2024)
8.3.2 China NGS-based RNA-sequencing Market Size by Application (2025-2030)
8.3.3 China NGS-based RNA-sequencing Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia NGS-based RNA-sequencing Market Size (2019-2030)
9.2 Asia NGS-based RNA-sequencing Market Size by Type
9.2.1 Asia NGS-based RNA-sequencing Market Size by Type (2019-2024)
9.2.2 Asia NGS-based RNA-sequencing Market Size by Type (2025-2030)
9.2.3 Asia NGS-based RNA-sequencing Market Share by Type (2019-2030)
9.3 Asia NGS-based RNA-sequencing Market Size by Application
9.3.1 Asia NGS-based RNA-sequencing Market Size by Application (2019-2024)
9.3.2 Asia NGS-based RNA-sequencing Market Size by Application (2025-2030)
9.3.3 Asia NGS-based RNA-sequencing Market Share by Application (2019-2030)
9.4 Asia NGS-based RNA-sequencing Market Size by Region
9.4.1 Asia NGS-based RNA-sequencing Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia NGS-based RNA-sequencing Market Size by Region (2019-2024)
9.4.3 Asia NGS-based RNA-sequencing Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size by Type
10.2.1 Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size by Application
10.3.1 Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size by Country
10.4.1 Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina NGS-based RNA-sequencing Introduction
11.1.4 Illumina Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.1.5 Illumina Recent Developments
11.2 Thermo Fischer Scientific
11.2.1 Thermo Fischer Scientific Company Details
11.2.2 Thermo Fischer Scientific Business Overview
11.2.3 Thermo Fischer Scientific NGS-based RNA-sequencing Introduction
11.2.4 Thermo Fischer Scientific Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.2.5 Thermo Fischer Scientific Recent Developments
11.3 Oxford Nanopore
11.3.1 Oxford Nanopore Company Details
11.3.2 Oxford Nanopore Business Overview
11.3.3 Oxford Nanopore NGS-based RNA-sequencing Introduction
11.3.4 Oxford Nanopore Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.3.5 Oxford Nanopore Recent Developments
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies NGS-based RNA-sequencing Introduction
11.4.4 Agilent Technologies Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.4.5 Agilent Technologies Recent Developments
11.5 BGI
11.5.1 BGI Company Details
11.5.2 BGI Business Overview
11.5.3 BGI NGS-based RNA-sequencing Introduction
11.5.4 BGI Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.5.5 BGI Recent Developments
11.6 PerkinElmer
11.6.1 PerkinElmer Company Details
11.6.2 PerkinElmer Business Overview
11.6.3 PerkinElmer NGS-based RNA-sequencing Introduction
11.6.4 PerkinElmer Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.6.5 PerkinElmer Recent Developments
11.7 QIAGEN
11.7.1 QIAGEN Company Details
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN NGS-based RNA-sequencing Introduction
11.7.4 QIAGEN Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.7.5 QIAGEN Recent Developments
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Details
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific NGS-based RNA-sequencing Introduction
11.8.4 Eurofins Scientific Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.8.5 Eurofins Scientific Recent Developments
11.9 Roche
11.9.1 Roche Company Details
11.9.2 Roche Business Overview
11.9.3 Roche NGS-based RNA-sequencing Introduction
11.9.4 Roche Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.9.5 Roche Recent Developments
11.10 Takara Bio
11.10.1 Takara Bio Company Details
11.10.2 Takara Bio Business Overview
11.10.3 Takara Bio NGS-based RNA-sequencing Introduction
11.10.4 Takara Bio Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.10.5 Takara Bio Recent Developments
11.11 GENEWIZ
11.11.1 GENEWIZ Company Details
11.11.2 GENEWIZ Business Overview
11.11.3 GENEWIZ NGS-based RNA-sequencing Introduction
11.11.4 GENEWIZ Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.11.5 GENEWIZ Recent Developments
11.12 Hamilton
11.12.1 Hamilton Company Details
11.12.2 Hamilton Business Overview
11.12.3 Hamilton NGS-based RNA-sequencing Introduction
11.12.4 Hamilton Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.12.5 Hamilton Recent Developments
11.13 Macrogen
11.13.1 Macrogen Company Details
11.13.2 Macrogen Business Overview
11.13.3 Macrogen NGS-based RNA-sequencing Introduction
11.13.4 Macrogen Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.13.5 Macrogen Recent Developments
11.14 Zymo Research
11.14.1 Zymo Research Company Details
11.14.2 Zymo Research Business Overview
11.14.3 Zymo Research NGS-based RNA-sequencing Introduction
11.14.4 Zymo Research Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.14.5 Zymo Research Recent Developments
11.15 Tecan Genomics
11.15.1 Tecan Genomics Company Details
11.15.2 Tecan Genomics Business Overview
11.15.3 Tecan Genomics NGS-based RNA-sequencing Introduction
11.15.4 Tecan Genomics Revenue in NGS-based RNA-sequencing Business (2019-2024)
11.15.5 Tecan Genomics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global NGS-based RNA-sequencing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Sequencing by Synthesis
    Table 3. Key Players of Ion Semiconductor Sequencing
    Table 4. Key Players of Single-molecule Real-time Sequencing
    Table 5. Key Players of Nanopore Sequencing
    Table 6. Global NGS-based RNA-sequencing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global NGS-based RNA-sequencing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global NGS-based RNA-sequencing Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global NGS-based RNA-sequencing Market Share by Region (2019-2024)
    Table 10. Global NGS-based RNA-sequencing Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global NGS-based RNA-sequencing Market Share by Region (2025-2030)
    Table 12. NGS-based RNA-sequencing Market Trends
    Table 13. NGS-based RNA-sequencing Market Drivers
    Table 14. NGS-based RNA-sequencing Market Challenges
    Table 15. NGS-based RNA-sequencing Market Restraints
    Table 16. Global NGS-based RNA-sequencing Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global NGS-based RNA-sequencing Revenue Share by Players (2019-2024)
    Table 18. Global Top NGS-based RNA-sequencing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-based RNA-sequencing as of 2023)
    Table 19. Global NGS-based RNA-sequencing Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by NGS-based RNA-sequencing Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of NGS-based RNA-sequencing, Headquarters and Area Served
    Table 22. Global Key Players of NGS-based RNA-sequencing, Product and Application
    Table 23. Global Key Players of NGS-based RNA-sequencing, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global NGS-based RNA-sequencing Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global NGS-based RNA-sequencing Revenue Market Share by Type (2019-2024)
    Table 27. Global NGS-based RNA-sequencing Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global NGS-based RNA-sequencing Revenue Market Share by Type (2025-2030)
    Table 29. Global NGS-based RNA-sequencing Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global NGS-based RNA-sequencing Revenue Share by Application (2019-2024)
    Table 31. Global NGS-based RNA-sequencing Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global NGS-based RNA-sequencing Revenue Share by Application (2025-2030)
    Table 33. North America NGS-based RNA-sequencing Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America NGS-based RNA-sequencing Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America NGS-based RNA-sequencing Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America NGS-based RNA-sequencing Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America NGS-based RNA-sequencing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America NGS-based RNA-sequencing Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America NGS-based RNA-sequencing Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe NGS-based RNA-sequencing Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe NGS-based RNA-sequencing Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe NGS-based RNA-sequencing Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe NGS-based RNA-sequencing Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe NGS-based RNA-sequencing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe NGS-based RNA-sequencing Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe NGS-based RNA-sequencing Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China NGS-based RNA-sequencing Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China NGS-based RNA-sequencing Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China NGS-based RNA-sequencing Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China NGS-based RNA-sequencing Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia NGS-based RNA-sequencing Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia NGS-based RNA-sequencing Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia NGS-based RNA-sequencing Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia NGS-based RNA-sequencing Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia NGS-based RNA-sequencing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia NGS-based RNA-sequencing Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia NGS-based RNA-sequencing Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America NGS-based RNA-sequencing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Illumina Company Details
    Table 66. Illumina Business Overview
    Table 67. Illumina NGS-based RNA-sequencing Product
    Table 68. Illumina Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)
    Table 69. Illumina Recent Developments
    Table 70. Thermo Fischer Scientific Company Details
    Table 71. Thermo Fischer Scientific Business Overview
    Table 72. Thermo Fischer Scientific NGS-based RNA-sequencing Product
    Table 73. Thermo Fischer Scientific Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)
    Table 74. Thermo Fischer Scientific Recent Developments
    Table 75. Oxford Nanopore Company Details
    Table 76. Oxford Nanopore Business Overview
    Table 77. Oxford Nanopore NGS-based RNA-sequencing Product
    Table 78. Oxford Nanopore Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)
    Table 79. Oxford Nanopore Recent Developments
    Table 80. Agilent Technologies Company Details
    Table 81. Agilent Technologies Business Overview
    Table 82. Agilent Technologies NGS-based RNA-sequencing Product
    Table 83. Agilent Technologies Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)
    Table 84. Agilent Technologies Recent Developments
    Table 85. BGI Company Details
    Table 86. BGI Business Overview
    Table 87. BGI NGS-based RNA-sequencing Product
    Table 88. BGI Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)
    Table 89. BGI Recent Developments
    Table 90. PerkinElmer Company Details
    Table 91. PerkinElmer Business Overview
    Table 92. PerkinElmer NGS-based RNA-sequencing Product
    Table 93. PerkinElmer Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)
    Table 94. PerkinElmer Recent Developments
    Table 95. QIAGEN Company Details
    Table 96. QIAGEN Business Overview
    Table 97. QIAGEN NGS-based RNA-sequencing Product
    Table 98. QIAGEN Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)
    Table 99. QIAGEN Recent Developments
    Table 100. Eurofins Scientific Company Details
    Table 101. Eurofins Scientific Business Overview
    Table 102. Eurofins Scientific NGS-based RNA-sequencing Product
    Table 103. Eurofins Scientific Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)
    Table 104. Eurofins Scientific Recent Developments
    Table 105. Roche Company Details
    Table 106. Roche Business Overview
    Table 107. Roche NGS-based RNA-sequencing Product
    Table 108. Roche Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)
    Table 109. Roche Recent Developments
    Table 110. Takara Bio Company Details
    Table 111. Takara Bio Business Overview
    Table 112. Takara Bio NGS-based RNA-sequencing Product
    Table 113. Takara Bio Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)
    Table 114. Takara Bio Recent Developments
    Table 115. GENEWIZ Company Details
    Table 116. GENEWIZ Business Overview
    Table 117. GENEWIZ NGS-based RNA-sequencing Product
    Table 118. GENEWIZ Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)
    Table 119. GENEWIZ Recent Developments
    Table 120. Hamilton Company Details
    Table 121. Hamilton Business Overview
    Table 122. Hamilton NGS-based RNA-sequencing Product
    Table 123. Hamilton Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)
    Table 124. Hamilton Recent Developments
    Table 125. Macrogen Company Details
    Table 126. Macrogen Business Overview
    Table 127. Macrogen NGS-based RNA-sequencing Product
    Table 128. Macrogen Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)
    Table 129. Macrogen Recent Developments
    Table 130. Zymo Research Company Details
    Table 131. Zymo Research Business Overview
    Table 132. Zymo Research NGS-based RNA-sequencing Product
    Table 133. Zymo Research Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)
    Table 134. Zymo Research Recent Developments
    Table 135. Tecan Genomics Company Details
    Table 136. Tecan Genomics Business Overview
    Table 137. Tecan Genomics NGS-based RNA-sequencing Product
    Table 138. Tecan Genomics Revenue in NGS-based RNA-sequencing Business (2019-2024) & (US$ Million)
    Table 139. Tecan Genomics Recent Developments
    Table 140. Research Programs/Design for This Report
    Table 141. Key Data Information from Secondary Sources
    Table 142. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global NGS-based RNA-sequencing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global NGS-based RNA-sequencing Market Share by Type: 2023 VS 2030
    Figure 3. Sequencing by Synthesis Features
    Figure 4. Ion Semiconductor Sequencing Features
    Figure 5. Single-molecule Real-time Sequencing Features
    Figure 6. Nanopore Sequencing Features
    Figure 7. Global NGS-based RNA-sequencing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global NGS-based RNA-sequencing Market Share by Application: 2023 VS 2030
    Figure 9. Research & Academia Case Studies
    Figure 10. Hospitals & Clinics Case Studies
    Figure 11. Pharmaceutical & Biotechnology Companies Case Studies
    Figure 12. Others Case Studies
    Figure 13. NGS-based RNA-sequencing Report Years Considered
    Figure 14. Global NGS-based RNA-sequencing Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global NGS-based RNA-sequencing Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global NGS-based RNA-sequencing Market Share by Region: 2023 VS 2030
    Figure 17. Global NGS-based RNA-sequencing Market Share by Players in 2023
    Figure 18. Global Top NGS-based RNA-sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NGS-based RNA-sequencing as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by NGS-based RNA-sequencing Revenue in 2023
    Figure 20. North America NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America NGS-based RNA-sequencing Market Share by Type (2019-2030)
    Figure 22. North America NGS-based RNA-sequencing Market Share by Application (2019-2030)
    Figure 23. North America NGS-based RNA-sequencing Market Share by Country (2019-2030)
    Figure 24. United States NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe NGS-based RNA-sequencing Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe NGS-based RNA-sequencing Market Share by Type (2019-2030)
    Figure 28. Europe NGS-based RNA-sequencing Market Share by Application (2019-2030)
    Figure 29. Europe NGS-based RNA-sequencing Market Share by Country (2019-2030)
    Figure 30. Germany NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China NGS-based RNA-sequencing Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China NGS-based RNA-sequencing Market Share by Type (2019-2030)
    Figure 38. China NGS-based RNA-sequencing Market Share by Application (2019-2030)
    Figure 39. Asia NGS-based RNA-sequencing Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia NGS-based RNA-sequencing Market Share by Type (2019-2030)
    Figure 41. Asia NGS-based RNA-sequencing Market Share by Application (2019-2030)
    Figure 42. Asia NGS-based RNA-sequencing Market Share by Region (2019-2030)
    Figure 43. Japan NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Share by Application (2019-2030)
    Figure 52. Middle East, Africa, and Latin America NGS-based RNA-sequencing Market Share by Country (2019-2030)
    Figure 53. Brazil NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries NGS-based RNA-sequencing Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Illumina Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)
    Figure 60. Thermo Fischer Scientific Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)
    Figure 61. Oxford Nanopore Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)
    Figure 62. Agilent Technologies Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)
    Figure 63. BGI Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)
    Figure 64. PerkinElmer Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)
    Figure 65. QIAGEN Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)
    Figure 66. Eurofins Scientific Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)
    Figure 67. Roche Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)
    Figure 68. Takara Bio Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)
    Figure 69. GENEWIZ Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)
    Figure 70. Hamilton Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)
    Figure 71. Macrogen Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)
    Figure 72. Zymo Research Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)
    Figure 73. Tecan Genomics Revenue Growth Rate in NGS-based RNA-sequencing Business (2019-2024)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD